Ultrastructural effects of oritavancin on methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 2, 2009, Pages 800-804

  Belley, Adam ^a   Harris, Robert ^b   Beveridge, Terry ^b   Parr Jr , Tom ^a   Moeck, Gregory ^a  

^a Targanta Therapeutics Inc   (Canada)

^b MicroTEM Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ORITAVANCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; MEMBRANE STRUCTURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; CRYOELECTRON MICROSCOPY; ENTEROCOCCUS; GLYCOPEPTIDES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 59749103779     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00603-08     Document Type: Article

References (22)

1. Allen, N. E., and T. I. Nicas. 2003. Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol. Rev. 26:511-532.
2. Arhin, F., I. Sarmiento, A. Belley, G. McKay, D. Draghi, P. Grover, D. Sahm, T. R. Parr, Jr., and G. Moeck. 2008. Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing. Antimicrob. Agents Chemother. 52:1597-1603.
3. Arhin, F. F., I. Sarmiento, A. Belley, G. McKay, D. Draghi, P. Grover, D. Sahm, T. R. Parr, Jr., and G. Moeck. 2007. Influence of polysorbate 80 on susceptibility of gram-positive bacteria to oritavancin, abstr. P827. 17th Eur. Congr. Clin. Microbiol. Infect. Dis., Munich, Germany, 31 March to 3 April 2007. European Society of Clinical Microbiology and Infectious Diseases, Munich, Germany.
4. Arhin, F. F., I. Sarmiento, T. R. Parr, Jr., and G. Moeck. 2007. Mechanisms of action of oritavancin in Staphylococcus aureus, abstr. C1-1471. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2007. American Society for Microbiology, Washington, DC.
5. Belley, A., B. Harris, T. Beveridge, T. R. Parr, Jr., and G. Moeck. 2008. Cell wall and membrane effects of oritavancin on Staphylococcus aureus and Enterococcus faecalis, abstr. P537. 18th Eur. Congr. Clin. Microbiol. Infect. Dis., Barcelona, Spain, 19 to 22 April 2008. European Society of Clinical Microbiology and Infectious Diseases, Munich, Germany.
6. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, CLSI document M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, CLSI document M100-S18, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Giesbrecht, P., T. Kersten, H. Maidhof, and J. Wecke. 1998. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62:1371-1414.
9. Gilmore, M. S. 2002. The enterococci: pathogenesis, molecular biology, and antibiotic resistance. ASM Press, Washington, DC.
10. Kajimura, J., T. Fujiwara, S. Yamada, Y. Suzawa, T. Nishida, Y. Oyamada, I. Hayashi, J. Yamagishi, H. Komatsuzawa, and M. Sugai. 2005. Identification and molecular characterization of an N-acetylmuramyl-L-alanine amidase Sle1 involved in cell separation of Staphylococcus aureus. Mol. Microbiol. 58:1087-1101.
11. Kemper, M. A., M. M. Urrutia, T. J. Beveridge, A. L. Koch, and R. J. Doyle. 1993. Proton motive force may regulate cell wall-associated enzymes of Bacillus subtilis. J. Bacteriol. 175:5690-5696.
12. Matias, V. R., and T. J. Beveridge. 2007. Cryo-electron microscopy of cell division in Staphylococcus aureus reveals a mid-zone between nascent cross walls. Mol. Microbiol. 64:195-206.
13. McKay, G. A., S. Beaulieu, A. Belley, F. F. Arhin, T. R. Parr, Jr., and G. Moeck. 2007. In vitro time kill studies of oritavancin against drug-resistant isolates of Staphylococcus aureus and enterococci, abstr. E-1614. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2007. American Society for Microbiology, Washington, DC.
14. McKay, G. A., I. Fadhil, S. Beaulieu, S. Ciblat, A. R. Far, G. Moeck, and T. R. Parr, Jr. 2006. Oritavancin disrupts transmembrane potential and membrane integrity concomitantly with cell killing in Staphylococcus aureus and vancomycin-resistant enterococci, abstr. C1-682. 46th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA, 27 to 30 September 2006. American Society for Microbiology, Washington, DC.
15. NCCLS. 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline, document M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Pinho, M. G., and J. Errington. 2003. Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery. Mol. Microbiol. 50:871-881.
17. Renelli, M., B. Harris, T. Beveridge, and B. M. Benton. 2007. Transmission electron microscopy (TEM) study of the ultrastructural effects of telavancin, a novel lipoglycopeptide, on methicillin-resistant Staphylococcus aureus, abstr. C1-1470. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2007.
18. Reynolds, P. E. 1989. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
19. Silverman, J., B. Harris, N. Cotroneo, and T. Beveridge. 2004. Daptomycin (DAP) treatment induces membrane and cell wall alterations in Staphylococcus aureus, abstr. C1-2155. 43rd Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 14 to 17 September 2004.
20. Touhami, A., M. H. Jericho, and T. J. Beveridge. 2004. Atomic force microscopy of cell growth and division in Staphylococcus aureus. J. Bacteriol. 186:3286-3295.
21. Wang, T.-S. A., D. Kahne, and S. Walker. 2007. Probing the mechanism of inhibition of bacterial peptidoglycan glycosyltransferases by glycopeptide analogs, abstr. C1-1474. 47th Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2007.
22. Yamada, S., M. Sugai, H. Komatsuzawa, S. Nakashima, T. Oshida, A. Matsumoto, and H. Suginaka. 1996. An autolysin ring associated with cell separation of Staphylococcus aureus. J. Bacteriol. 178:1565-1571.